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Introduction
In its attempt to regulate interstate commerce of
chemicals within the United States, Congress cre-
ated five regulatory agencies with the burden of
overseeing various aspects of that trade. The
Environmental Protection Agency (EPA), the Con-
sumer Product Safety Commission (CPSC), the
UnitedStatesDepartmentofAgriculture/Food Safety
and Inspection Service (USDA/FSIS) the U.S.
Department of Labor and its Occupational Safety
and Health Administration (OSHA) and the Food
and Drug Administration (FDA) regulate the use of
chemicals in interstate commerce. Because each of
these agencies arose through different enabling
legislation and are concerned with a different use of
chemicals, it is likely that the same chemical would
be independently regulated by two or more ofthose
agencies. In addition, because chemicals and their
manufacture and use, in general, are a concern of
each of those agencies, policies and requirements
for safe use ofthose chemicals could be different for
each agency. For the above reasons, in October
1977, at the urging ofthe executive branch, each of
the agency heads of EPA, CPSC, FDA and OSHA
agreed to recommend those specific areas in which
interagency cooperation would be beneficial to all
agencies. Some areas ofconcern were finally agreed
upon by the agency heads.
In the area of toxicity testing guidelines, it was
important for each agency to require similar stan-
dards to prevent duplicative testing by industry.
Cooperation could result in a development of stan-
dardized testing guidelines which, if utilized in a
toxicity test, would be acceptable for safety stan-
dards among the agencies. Joint research planning
was another area where common interests could be
identified. Each agency could avoid unnecessary
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duplication in spending for research already being
performed by another agency. The third area was
informationexchange. Theobjectivewastoimprove
the quantity and quality ofinformation available to
each agency. Risk assessment was a fourth area
identified since it is essential that health and safety
decisions among agencies be made in a uniform
manner. It is also important that risk assessment
made by uniform decision making, identify poten-
tial problem areas. Fifth, it was also believed that
an inspector from a single agency could observe the
same territory as many inspectors from different
agencies had previously. This attempt to coordinate
inspection efforts was believed to increase the
efficiency and reduce the burden of inspection on
industry and government. Sixth, the agency heads
wantedtodetermine ifthereweresufficientresources
that could be pooled to develop a uniform federal
government agency response to problems of com-
mon concern to two or more agencies. Communica-
tionandeducationwereconsideredimportantbecause
it was felt that information transmitted to the
public on toxic substances should be consistent,
accurate, and educational. The development of a
uniform policy for review ofepidemiology data was
the eighth area where the agency heads felt that
there was common interest.
In October 1977, the agency heads formally
announced the creation ofthe Interagency Regula-
tory Liaison Group (IRLG). The stated goal ofthat
organization was "to increase the public health and
protect the environment by sharing information,
avoiding duplication of effort and developing con-
sistent regulatory policy while reducing the burden
onthose regulated and the agencies themselves (1).
It was decided to concentrate on research for
regulation ofhazardous substances on a nationwide
basis. Some operating concepts are to avoid creat-
inganotherlevel ofbureaucracy, to focus on action,
not studies. Coordination is the rule, not the
exception. It was deemed important to be certain146
Table 1. Chronology of development of Interagency Regula-
tory Liaison Group (IRLG) comprising Consumer Product
Safety Commission, Environmental Protection Agency, Food
And Drug Administration, HEW, Food Safety And Quality
Service, USDA, Occupational Safety And Health Administra-
tion, DOL.
Date Step
August 2, 1977 Announced intention to form IRLG
September 26, 1977 Signed agreement
October 11, 1977 Published agreement in Federal
Register
February 17, 1978 Published work plans in Federal
Register
March2-6, 1978 Work groups held public meetings
January, 1979 FSQS joined IRLG
May 22-23, 1979 Agency heads held public meetings
that arrangements make good sense and to empha-
size quality regional coordination.
In September 1977, an interagency agreement
was signed by each agency head to commence this
newly created "Confederation of Agencies." Draft
work/action plans were prepared and published in
the Federal Register in February 1978 (2). Finally
inJanuary 1979, theDepartmentofAgriculture/Food
Safety and Inspection Service, as it is now known,
joined the IRLG (Table 1).
Organization of IRLG
IRLG as agroup ofagencies has onlyone fulltime
employee. This is to reinforce the idea that agency
employees are also members of the IRLG. Each
member agency designates part of its operating
budget for the funding of IRLG programs.
The IRLG is directed by the five agency heads.
Day-to-day activities of the agencies are overseen
by two surrogates from each agency. The substruc-
ture below the surrogates consists ofregional staff,
task groups, work groups, senior headquarters
staff and operating staff, but there is no set
organizational hierarchy as to how these groups
interact. The organization is flexible to allow for
unexpected emergencies where one group will be
required to interact with another.
Regulatory development is one of the groups
within working groups. It is a work group consist-
ing of20 subwork groups which each are concerned
with a chemical of concern to at least two of the
member agencies (Table 2). Twice ayeareach work
group publishes areport on their activities in a free
booklet called The Regulatory Reporter. Copies of
the Regulatory Reporter are available from EPA;
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Table 2. Work groups and counterpart groups.
Work Groups Counterpart Groups Regions
Epidemiology Budget I: Boston
Infornation Compliance and II: New York
Exchange Enforcement
Regulatory Congressional Affairs III: Philadelphia
Development
Testing Standards Contracts IV: Atlanta
And Guidelines
Education Task Economists V: Chicago
Force
Freedom Of VI: Dallas
Information
General Counsels VII: Kansas City
Personnel VIII: Denver
Planning and IX: San Francisco
Evaluation
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Soon after the results of National Cancer Insti-
tute Carcinogenic Bioassay on di(2-ethylhexyl)
phthalate(DEHP), di(2-ethylhexyl)adipate(DEHA)
and butyl benzyl phthalate (BBP) became available
in draft form, it became apparent that each of the
member agencies of IRLG would be concerned
about the results and possibly interested in future
reregulation ofthose compounds based on the NCI
data.
IRLG immediately responded by forming a new
work group on plasticizers. Each Member agency
appointed a representative (it should be apparent
that if a particular agency had no interest in the
regulation of a compound, it would not appoint a
representative). Because ofthe diverse interests in
plasticizers, the work group has had representa-
tives of a number ofnon-IRLG agencies, including
the Department of Defense (DOD), the National
Toxicology Program (NTP), The National Institute
of Occupational Health and Safety (NIOSH), and
the NuclearRegulatory Commission (NRC), attend
its meetings. The work group agreed that DEHP,
DEHA and BBP were of primary concern; howev-
er, any possible alternative for those compounds
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group. It was also of general consensus that all
toxicology and exposure data available within an
individual agency would be exchanged so that the
same database would be considered by allinvolved.
It was obvious that the data base for toxicity
studies on phthalates was large. However, the only
long-term studies on phthalates other than the
recent NCI studies were completed in the middle
1950s. Although negative in terms ofcarcinogenici-
ty, those studies were not conducted under present
day testing standards. It was a concern of the
IRLGscientistrepresentingeachagencythatadvice
from outside the U.S. government on the generally
accepted interpretation of those results be sought
out. As a result, the work group agreed that a
conference consisting of recognized experts in the
field ofphthalates and carcinogenesis could provide
the work group and member agencies enough
background on manufacturing, exposure, toxicol-
ogy and testing rationale data so that regulatory
decisions on the matter could be made by each
agency.
Agreements were made between the NTP and
IRLGwho sponsored this conference onphthalates.
The work group felt that a conference held prior to
commencement of any formal regulatory action
would allow participants to freely air their views
without a cloud of pending regulatory activity
which might restrict the free flow of ideas.
The information gained from the conference is
presently being considered by the agencies and
work group. The information was valuable and
helped the work group understand many of the
issues involved with the problem.
The workgroup is now continuing its efforts by
working with the NTP and the Chemical Manufac-
turers Association to develop a clearinghouse for
ongoingtoxicologicalstudiesbeingconductedthrough-
out the world. This program is presently being
initiated and it is hopeful that it can prevent
duplication ofexperimentation by scientists through-
out the world and continue the open dialogue for
discussionoftheinterpretationofthesenewresults.
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